Skip to main content

Miscellaneous Central Nervous System Depressants

  • Chapter
  • First Online:
  • 3495 Accesses

Abstract

Central nervous system (CNS) depressants remain a frequently encountered class of drugs in forensic toxicology. The most commonly encountered group, the benzodiazepines are discussed in Chap. 20. The oldest group of CNS depressants, the barbiturates, are still used therapeutically, principally as anesthetic agents and anticonvulsants. Barbiturates are classified based on their chemical structure, duration of action, and pharmacological properties. Gamma-hydroxybutyric acid (GHB) is a simple hydroxylated, short-chain fatty acid with a very short duration of action. However, its detection in biological specimens is complicated by the fact that it is also produced endogenously from the metabolism of the neurotransmitter gamma-aminobutyric acid (GABA) and is produced in postmortem blood specimens. Zolpidem, zopiclone, and zaleplon, collectively known as “z-drugs,” all interact with the GABA receptor in different ways to produce their CNS depressant effects. Some of the newer CNS depressants that are used to manage sleep disorders include melatonin agonists such as ramelteon and tasimelteon, and dual orexin receptor antagonists such as suvorexant. Other sedative-hypnotics, muscle relaxants, and drugs with CNS depressant activity are also discussed.

This is publication 19–20 of the FBI Laboratory Division. Names of commercial manufacturers are provided for identification purposes only, and inclusion does not imply endorsement of the manufacturer or its products or services by the FBI. The views expressed are those of the authors and do not necessarily reflect the official policy or position of the FBI or the US Government.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   84.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Suggested Reading

  • Baselt RC (2020) Disposition of toxic drugs and chemicals in man, 12th edn. Biomedical Publications, Seal Beach, CA

    Google Scholar 

  • Borgen LA, Okerholm RA, Lai A, Scharf MB (2004) The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients. J Clin Pharmacol 44:253–257

    Article  CAS  Google Scholar 

  • Brailsford AD, Cowan DA, Kicman AT (2012) Pharmacokinetic properties of gamma-hydroxybutyrate (GHB) in whole blood, serum, and urine. J Anal Toxicol 36:88–95

    Article  CAS  Google Scholar 

  • Brenneisen R, Elsohly MA, Murphy TP, Passarelli J, Russmann S, Salamone SJ et al (2004) Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. J Anal Toxicol 28:625–630

    Article  CAS  Google Scholar 

  • Brunton LL, Lazo JS, Parker KL, Gilman AG (eds) (2006) Goodman and Gilman’s The pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York

    Google Scholar 

  • Busardo FB, Jones AW (2015) GHB pharmacology and toxicology: Acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Current Neuropharm 13:47–70

    Article  CAS  Google Scholar 

  • Dooley M, Plosker GL (2000) Zaleplon-A review of its use in the treatment of insomnia. Drugs 60:413–445

    Article  CAS  Google Scholar 

  • Fieler EL, Coleman DE, Baselt RC (1998) Gammahydroxybutyrate concentrations in pre- and postmortem blood and urine. Clin Chem 44:692

    Article  CAS  Google Scholar 

  • Kavanagh PV, Kenny P, Feely J (2001) The urinary excretion of gamma-hydroxybutyric acid in man. J Pharm Pharmacol 53:399–402

    Article  CAS  Google Scholar 

  • Kerrigan S (2002) In vitro production of gammahydroxybutyrate in antemortem urine samples. J Anal Toxicol 26:571–574

    Article  CAS  Google Scholar 

  • Langtry HD, Benfield P (1990) Zolpidem: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 40:291–313

    Article  CAS  Google Scholar 

  • LeBeau MA, Montgomery MA, Jufer RA, Miller ML (2000) Elevated GHB in citrate-buffered blood. J Anal Toxicol 24:383

    Article  CAS  Google Scholar 

  • LeBeau MA, Miller ML, Levine B (2001) Effect of storage temperature on endogenous GHB levels in urine. Forensic Sci Int 119:161–167

    Article  CAS  Google Scholar 

  • LeBeau MA, Christenson RH, Levine B, Darwin WD, Huestis MA (2002) Intra- and interindividual variations in urinary concentrations of endogenous gamma- hydroxybutyrate. J Anal Toxicol 26:340–346

    Article  CAS  Google Scholar 

  • Mahmood I, Sahajwalla C (1999) Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Clin Pharmacokinet 36:277–287

    Article  CAS  Google Scholar 

  • Palatini P, Tedeschi L, FrisonG PR, Zordan R, Orlando R et al (1993) Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol 45:353–356

    Article  CAS  Google Scholar 

  • Rohrig TP, Moore CM (2005) Zolpidem-Forensic Aspects for the toxicologist and pathologist. Forensic Sci Med Path 1:81–90

    Article  CAS  Google Scholar 

  • Srinivasan V, Brezinski A, Oter S, Shillcutt SD (eds) Melatonin and melatonin drugs in clinical practice. Springer, New Dehli

    Google Scholar 

  • Torres R, Dressman MA, Kramer WG, Baroldi P (2015) Absolute bioavailability of tasimelteon. Amer J Therapeutics 22:355–360

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barry S. Levine .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Levine, B.S., LeBeau, M. (2020). Miscellaneous Central Nervous System Depressants. In: Levine, B.S., KERRIGAN, S. (eds) Principles of Forensic Toxicology. Springer, Cham. https://doi.org/10.1007/978-3-030-42917-1_21

Download citation

Publish with us

Policies and ethics